ETHK Labs Inc.

HK$0.34As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1931Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR (23.83%)
Div yield —
ROE (2.65%)
Medical Distribution
Beta (5Y) (0.32)
PE TTM —
TSR TTM (95.06%)
Mkt cap HK$553.5M
ROIC (0.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.352
1.99%
(5.50%)
Hold 12|10|2|6|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
—
—
—
—
13.18%
9.56%
7.34%
10.72%
Revenue¥M
59.81
60.53
59.31
58.50
7.20%
9.84%
2.99%
(0.13%)
Peers (US$70.60M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.970
(0.845)
(0.696)
EBIT/Intx
0.351
0.092
0.101
Own earn%
426.49
(177.02)
(162.24)
Sh yield%
55.78
37.25
36.37
Owners
Insiders/Inst%
4.55
62.26
Short interest%
5.04
SBC / revenue%
3.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
22–29
$1 testx
—
Incr. ROIC%
0